Index RUT
P/E -
EPS (ttm) -2.20
Insider Own 2.31%
Shs Outstand 48.97M
Perf Week -2.63%
Market Cap 781.23M
Forward P/E -
EPS next Y -0.97
Insider Trans -6.27%
Shs Float 47.85M
Perf Month -14.06%
Income -107.59M
PEG -
EPS next Q -0.35
Inst Own 103.50%
Short Float 9.26%
Perf Quarter 5.21%
Sales 233.25M
P/S 3.35
EPS this Y 41.26%
Inst Trans -0.41%
Short Ratio 9.97
Perf Half Y 67.54%
Book/sh 9.45
P/B 1.69
EPS next Y 25.03%
ROA -9.94%
Short Interest 4.43M
Perf Year -23.94%
Cash/sh 9.33
P/C 1.71
EPS next 5Y -
ROE -19.06%
52W Range 9.00 - 24.17
Perf YTD 2.97%
Dividend Est. -
P/FCF -
EPS past 5Y -45.48%
ROI -11.96%
52W High -34.01%
Beta 1.73
Dividend TTM -
Quick Ratio 11.16
Sales past 5Y 78.51%
Gross Margin 35.60%
52W Low 77.22%
ATR (14) 0.91
Dividend Ex-Date -
Current Ratio 11.73
EPS Y/Y TTM -137.82%
Oper. Margin -25.14%
RSI (14) 42.62
Volatility 6.03% 4.71%
Employees 1170
Debt/Eq 0.85
Sales Y/Y TTM -1.70%
Profit Margin -46.12%
Recom 2.20
Target Price 18.00
Option/Short Yes / Yes
LT Debt/Eq 0.84
EPS Q/Q -457.68%
Payout -
Rel Volume 1.19
Prev Close 17.16
Sales Surprise -1.94%
EPS Surprise -362.41%
Sales Q/Q -5.13%
Earnings May 07 AMC
Avg Volume 444.54K
Price 15.95
SMA20 -6.32%
SMA50 -5.65%
SMA200 8.29%
Trades
Volume 530,468
Change -7.05%
Date
Action
Analyst
Rating Change
Price Target Change
May-03-24 Downgrade
B. Riley Securities
Buy → Neutral
$22 → $19
Apr-04-24 Resumed
Jefferies
Buy
$17 → $21
Mar-13-24 Reiterated
Needham
Buy
$19 → $18
Aug-17-23 Initiated
Morgan Stanley
Equal-Weight
$16
Aug-10-23 Downgrade
Stephens
Overweight → Equal-Weight
$15
Jul-18-23 Downgrade
UBS
Buy → Neutral
$28 → $17
Jul-17-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-13-23 Downgrade
SVB Securities
Outperform → Market Perform
$30 → $10
Jan-19-22 Upgrade
ROTH Capital
Neutral → Buy
$90
Nov-05-21 Downgrade
ROTH Capital
Buy → Neutral
$78 → $90
Oct-19-21 Resumed
B. Riley Securities
Buy
$81
Jul-16-21 Initiated
BTIG Research
Buy
$80
Mar-15-21 Initiated
UBS
Buy
$84
Mar-02-21 Resumed
Needham
Buy
$73
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$54
Jan-08-20 Initiated
Stephens
Overweight
$21
Jul-01-19 Resumed
Needham
Buy
$22
Oct-10-18 Initiated
B. Riley FBR
Buy
$22
Aug-13-18 Reiterated
Cowen
Outperform
$11 → $16
Jul-02-18 Reiterated
Needham
Buy
$11 → $19
Show Previous Ratings
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
05:52PM
Loading…
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
Nov-21-23 03:26PM
Nov-16-23 08:30AM
Nov-09-23 05:23PM
06:05PM
Loading…
Nov-08-23 06:05PM
04:05PM
Nov-02-23 08:30AM
Oct-26-23 10:02AM
Oct-25-23 08:30AM
Oct-12-23 08:30AM
Oct-10-23 08:30AM
Oct-09-23 04:05PM
Sep-14-23 08:30AM
Aug-10-23 07:14AM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 08:30AM
Jul-31-23 08:53AM
Jul-23-23 08:17AM
12:24PM
Loading…
Jul-13-23 12:24PM
11:17AM
Jul-12-23 04:05PM
12:56PM
Jun-29-23 08:39AM
May-25-23 08:02AM
May-12-23 07:15AM
May-04-23 06:05PM
04:05PM
Apr-27-23 10:02AM
08:30AM
Apr-25-23 08:30AM
Apr-01-23 08:54AM
Mar-28-23 08:30AM
Mar-16-23 03:46AM
Mar-13-23 06:00AM
Mar-08-23 01:15PM
Feb-23-23 06:40PM
04:05PM
Feb-15-23 08:30AM
Jan-29-23 07:31AM
Jan-26-23 10:55AM
Jan-18-23 08:30AM
Dec-20-22 08:30AM
Dec-19-22 07:15AM
Nov-08-22 06:56AM
Nov-07-22 08:10PM
05:03AM
Nov-03-22 06:45PM
04:05PM
Oct-27-22 08:30AM
05:32AM
Sep-08-22 08:30AM
Aug-08-22 02:42PM
(Investor's Business Daily) +6.83%
Aug-06-22 10:18AM
Aug-05-22 09:55AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 08:30AM
Jul-01-22 08:57AM
May-05-22 07:05PM
04:05PM
Apr-28-22 08:30AM
Apr-20-22 05:59PM
(American City Business Journals)
Apr-19-22 12:24PM
(American City Business Journals)
Apr-18-22 03:11PM
(American City Business Journals)
08:30AM
Mar-30-22 05:00PM
Mar-11-22 03:40PM
Feb-24-22 06:30PM
04:05PM
Feb-23-22 10:00AM
Feb-17-22 03:02PM
Feb-15-22 08:30AM
Feb-09-22 09:29AM
Feb-08-22 09:38AM
Feb-01-22 05:38PM
Jan-31-22 05:35PM
Jan-28-22 05:46AM
Jan-27-22 08:30AM
Jan-26-22 05:38PM
Jan-21-22 05:38PM
09:38AM
Jan-05-22 01:38PM
08:30AM
Dec-16-21 03:38AM
Dec-15-21 01:15PM
Dec-13-21 04:38PM
Dec-05-21 08:05AM
Nov-26-21 04:01PM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SHELTON JERRELL Chief Executive Officer Mar 25 '24 Sale 17.54 2,631 46,154 692,182 Mar 26 08:09 PM Sawicki Mark W Chief Scientific Officer Mar 25 '24 Sale 17.54 1,367 23,980 77,444 Mar 26 08:08 PM STEFANOVICH ROBERT Chief Financial Officer Mar 25 '24 Sale 17.54 1,079 18,928 128,333 Mar 26 08:12 PM SHELTON JERRELL President, CEO Mar 15 '24 Option Exercise 4.80 100,000 480,000 749,253 Mar 19 07:48 PM Mandalam Ramkumar Director Mar 15 '24 Option Exercise 5.40 8,334 45,004 46,404 Mar 19 07:49 PM BADDOUR LINDA Director Mar 15 '24 Option Exercise 0.00 1,111 0 21,690 Mar 19 07:48 PM SHELTON JERRELL President, CEO Mar 15 '24 Sale 15.30 57,039 872,884 634,352 Mar 19 07:48 PM Mandalam Ramkumar Director Mar 15 '24 Sale 14.68 3,217 47,226 43,187 Mar 19 07:49 PM Sawicki Mark W Chief Scientific Officer Mar 15 '24 Sale 15.43 1,312 20,247 73,061 Mar 19 07:50 PM STEFANOVICH ROBERT Chief Financial Officer Mar 15 '24 Sale 15.43 1,035 15,972 123,662 Mar 19 07:51 PM SHELTON JERRELL President, CEO Mar 11 '24 Sale 16.35 3,723 60,880 636,951 Mar 19 07:48 PM Sawicki Mark W Chief Scientific Officer Mar 11 '24 Sale 16.35 1,418 23,188 74,373 Mar 19 07:50 PM STEFANOVICH ROBERT Chief Financial Officer Mar 11 '24 Sale 16.35 1,119 18,298 124,697 Mar 19 07:51 PM STEFANOVICH ROBERT Chief Financial Officer Mar 09 '24 Option Exercise 0.00 2,666 0 125,816 Mar 19 07:51 PM SHELTON JERRELL President, CEO Mar 09 '24 Option Exercise 0.00 8,250 0 640,674 Mar 19 07:48 PM Sawicki Mark W Chief Scientific Officer Mar 09 '24 Option Exercise 0.00 2,666 0 75,791 Mar 19 07:50 PM Hariri Robert J Director Dec 14 '23 Sale 16.89 800 13,512 12,716 Dec 18 07:19 PM Hariri Robert J Director Dec 11 '23 Sale 15.50 1,000 15,500 13,516 Dec 13 06:02 PM Sawicki Mark W Chief Scientific Officer Sep 12 '23 Option Exercise 12.79 1,000 12,790 73,125 Sep 13 05:01 PM Hariri Robert J Director Sep 06 '23 Sale 13.60 1,500 20,400 14,516 Sep 12 06:01 PM SHELTON JERRELL See Remarks Sep 01 '23 Option Exercise 1.87 54,000 100,980 659,299 Sep 05 05:53 PM SHELTON JERRELL See Remarks Sep 01 '23 Sale 14.27 26,875 383,407 632,424 Sep 05 05:53 PM STEFANOVICH ROBERT Chief Financial Officer Aug 29 '23 Option Exercise 3.07 16,000 49,120 123,150 Aug 30 05:30 PM BERMAN RICHARD J Director May 11 '23 Sale 21.51 7,203 154,906 100,000 May 12 06:22 PM SHELTON JERRELL President, CEO May 10 '23 Option Exercise 3.24 286,377 927,861 746,458 May 12 06:22 PM STEFANOVICH ROBERT Chief Financial Officer May 10 '23 Option Exercise 3.24 19,918 64,534 127,068 May 12 06:21 PM SHELTON JERRELL President, CEO May 10 '23 Sale 21.63 141,159 3,053,509 605,299 May 12 06:22 PM STEFANOVICH ROBERT Chief Financial Officer May 10 '23 Sale 21.94 19,918 437,023 107,150 May 12 06:21 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite